Acrivon Therapeutics, Inc. · NASDAQ:ACRV
RA Capital Nexus Fund II, L.P. received 9,366 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, RA Capital Nexus Fund II, L.P. (Director) received 9,366 Acrivon Therapeutics, Inc. shares as an award, leaving 9,366 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 9,366 shares
- Holding after
- 9,366 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 9,366 | 9,366 | Indirect |
Source
Related
- Acrivon Therapeutics, Inc.
- RA Capital Nexus Fund II, L.P.
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · RA Capital Nexus Fund II, L.P. · Apr 23, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026